PortfoliosLab logoPortfoliosLab logo
IBRN vs. IVV
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IBRN vs. IVV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Neuroscience and Healthcare ETF (IBRN) and iShares Core S&P 500 ETF (IVV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBRN achieves a 4.62% return, which is significantly lower than IVV's 11.70% return.


IBRN

1D
-4.52%
1M
-1.90%
YTD
4.62%
6M
12.73%
1Y
52.57%
3Y*
11.10%
5Y*
10Y*

IVV

1D
0.14%
1M
5.39%
YTD
11.70%
6M
12.12%
1Y
29.71%
3Y*
22.74%
5Y*
14.26%
10Y*
15.62%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBRN vs. IVV - Yearly Performance Comparison


2026 (YTD)2025202420232022
IBRN
iShares Neuroscience and Healthcare ETF
4.62%28.49%-2.78%0.92%5.85%
IVV
iShares Core S&P 500 ETF
11.70%17.85%24.93%26.31%-4.77%

Correlation

The correlation between IBRN and IVV is 0.53, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.53

Correlation (3Y)
Calculated over the trailing 3-year period

0.56

Correlation (All Time)
Calculated using the full available price history since Aug 29, 2022

0.58

The correlation between IBRN and IVV has been stable across timeframes, ranging from 0.53 to 0.58 - a consistent structural relationship.

IBRN vs. IVV - Sectors Allocation Comparison


Sectors
IBRN
IVV

Healthcare

100.0%
8.5%

Basic Materials

-

1.8%

Communication Services

-

11.2%

Consumer Cyclical

-

10.1%

Consumer Defensive

-

4.9%

Energy

-

3.5%

Financial Services

-

11.8%

Industrials

-

8.3%

Real Estate

-

1.9%

Technology

-

35.6%

Utilities

-

2.4%

Healthcare

IBRN
100.0%
IVV
8.5%

Basic Materials

IBRN

-

IVV
1.8%

Communication Services

IBRN

-

IVV
11.2%

Consumer Cyclical

IBRN

-

IVV
10.1%

Consumer Defensive

IBRN

-

IVV
4.9%

Energy

IBRN

-

IVV
3.5%

Financial Services

IBRN

-

IVV
11.8%

Industrials

IBRN

-

IVV
8.3%

Real Estate

IBRN

-

IVV
1.9%

Technology

IBRN

-

IVV
35.6%

Utilities

IBRN

-

IVV
2.4%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBRN vs. IVV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBRN
IBRN Risk / Return Rank: 6969
Overall Rank
IBRN Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
IBRN Sortino Ratio Rank: 6262
Sortino Ratio Rank
IBRN Omega Ratio Rank: 5353
Omega Ratio Rank
IBRN Calmar Ratio Rank: 9292
Calmar Ratio Rank
IBRN Martin Ratio Rank: 7979
Martin Ratio Rank

IVV
IVV Risk / Return Rank: 7575
Overall Rank
IVV Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
IVV Sortino Ratio Rank: 7575
Sortino Ratio Rank
IVV Omega Ratio Rank: 7777
Omega Ratio Rank
IVV Calmar Ratio Rank: 6868
Calmar Ratio Rank
IVV Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBRN vs. IVV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Neuroscience and Healthcare ETF (IBRN) and iShares Core S&P 500 ETF (IVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBRNIVVDifference

Sharpe ratio

Return per unit of total volatility

2.09

2.54

-0.45

Sortino ratio

Return per unit of downside risk

2.94

3.44

-0.50

Omega ratio

Gain probability vs. loss probability

1.34

1.46

-0.12

Calmar ratio

Return relative to maximum drawdown

6.30

3.43

+2.87

Martin ratio

Return relative to average drawdown

15.59

15.97

-0.37

IBRN vs. IVV - Sharpe Ratio Comparison

The current IBRN Sharpe Ratio is 2.09, which is comparable to the IVV Sharpe Ratio of 2.54. The chart below compares the historical Sharpe Ratios of IBRN and IVV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IBRNIVVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.09

2.54

-0.45

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.85

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.87

Sharpe Ratio (All Time)

Calculated using the full available price history

0.37

0.46

-0.09

Drawdowns

IBRN vs. IVV - Drawdown Comparison

The maximum IBRN drawdown since its inception was -35.38%, smaller than the maximum IVV drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for IBRN and IVV.


Loading charts...

Drawdown Indicators


IBRNIVVDifference

Max Drawdown

Largest peak-to-trough decline

-35.38%

-55.25%

+19.87%

Max Drawdown (1Y)

Largest decline over 1 year

-8.80%

-8.89%

+0.09%

Max Drawdown (3Y)

Largest decline over 3 years

-35.38%

-18.75%

-16.63%

Max Drawdown (5Y)

Largest decline over 5 years

-24.53%

Max Drawdown (10Y)

Largest decline over 10 years

-33.90%

Current Drawdown

Current decline from peak

-6.28%

0.00%

-6.28%

Average Drawdown

Average peak-to-trough decline

-9.83%

-10.78%

+0.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.56%

1.91%

+1.65%

Volatility

IBRN vs. IVV - Volatility Comparison

iShares Neuroscience and Healthcare ETF (IBRN) has a higher volatility of 7.66% compared to iShares Core S&P 500 ETF (IVV) at 2.75%. This indicates that IBRN's price experiences larger fluctuations and is considered to be riskier than IVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBRNIVVDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.66%

2.75%

+4.91%

Volatility (6M)

Calculated over the trailing 6-month period

19.29%

8.87%

+10.42%

Volatility (1Y)

Calculated over the trailing 1-year period

25.38%

11.78%

+13.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.32%

16.88%

+8.44%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.32%

18.05%

+7.27%

IBRN vs. IVV - Expense Ratio Comparison

IBRN has a 0.47% expense ratio, which is higher than IVV's 0.03% expense ratio.


Dividends

IBRN vs. IVV - Dividend Comparison

IBRN's dividend yield for the trailing twelve months is around 0.95%, less than IVV's 1.06% yield.


PositionTTM20252024202320222021202020192018201720162015
IBRN
iShares Neuroscience and Healthcare ETF
0.95%0.99%0.40%0.06%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IVV
iShares Core S&P 500 ETF
1.06%1.17%1.30%1.44%1.66%1.20%1.57%1.85%2.21%1.75%2.01%2.27%

Frequently Asked Questions


IBRN and IVV have a correlation of 0.53, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBRN has higher volatility (7.66%) compared to IVV (2.75%). In terms of maximum drawdown, IBRN dropped -35.38% vs IVV's -55.25%.

On 3-year performance, IVV leads with 22.74% vs 11.10% for IBRN. On fees, IVV is cheaper at 0.03% per year. On volatility, IVV has been the lower-risk option at 2.75%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, IVV has performed better with a 22.74% return vs 11.10%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IVV is cheaper with a 0.03% expense ratio, compared with 0.47% for IBRN.

IVV has the higher dividend yield at 1.06%, compared with 0.95% for IBRN.

IBRN is categorized as Health & Biotech Equities, while IVV is S&P 500. IBRN tracks NYSE FactSet Global Neuro Biopharma and MedTech Index, while IVV tracks S&P 500 Index. Their fees differ too: 0.47% for IBRN and 0.03% for IVV.

IVV currently has the higher Sharpe Ratio (2.54 vs 2.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBRN and IVV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer